# Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke

> **NCT04811651** · PHASE2 · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 156 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Umbilical Cord-derived Mesenchymal Stem Cells
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04811651
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811651, "Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04811651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*